Terazosin vs finasteride for BPH
Zacks, M.
Journal of Family Practice 43(6): 533
1996
ISSN/ISBN: 0094-3509 PMID: 8969692 Document Number: 464822
Document emailed within 1 workday
Related Documents
Trinkler, F.B. 1997: Therapy of benign prostatic hyperplasia: terazosin or finasteride? Praxis 86(34): 1305-1306Anwarul Islam, A.K.M.; Kashem, M.A.; Shameem, I.A.; Kibria, S.A.M.G. 2005: Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: a comparative study Bangladesh Medical Research Council Bulletin 31(2): 54-61
Ruutu, M.; Rannikko, A. 2004: Finasteride and prostate cancer Duodecim; Laaketieteellinen Aikakauskirja 120(5): 525-527
Ekman, P.; Andersen, J.T.; Wolf, H. 1996: Finasteride in the treatment of benign prostatic hyperplasia Acta Urologica Belgica 64(1): IX-XII
Rosenthal, J. 1989: Blood pressure and lipid lowering effects of terazosin Journal of Human Hypertension 3 Suppl. 2: 85-9; Discussion 90-1
Ricci, G.; Martinelli, M.; Luppi, S.; Lo Bello, L.; De Santis, M.; Skerk, K.; Zito, G. 2012: Finasteride and fertility: case report and review of the literature Journal of Drugs in Dermatology: Jdd 11(12): 1511-1513
Al Hammadi, A.; Asai, Y.; Patt, M.L.; Sasseville, D. 2007: Erythema annulare centrifugum secondary to treatment with finasteride Journal of Drugs in Dermatology: Jdd 6(4): 460-463
Larosa, M.; Ferretti, S.; Salsi, P.; Simonazzi, M. 1994: Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience Acta Bio-Medica de l'Ateneo Parmense 65(1-2): 23-28
Speck, L.M.; Wilkerson, M.G.; Perri, A.J.; Kelly, B.C. 2008: Acute generalized exanthematous pustulosis caused by terazosin hydrochloride Journal of Drugs in Dermatology: Jdd 7(4): 395-397
Paterna, S.; Martino, S.; Ingurgio, N.C.; Arrostuto, A.; Correo, S.; Licata, G. 1994: The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura La Clinica Terapeutica 144(4): 307-319
Wu, T.T.; Lee, Y.H.; Jiaan, B.P.; Huang, J.K. 1995: The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia Zhonghua Yi Xue Za Zhi 56(6): 399-403
Tarle, M.; Kraus, O.; Trnski, D.; Reljic, A.; Ruzic, B.; Katusic, J.; Spajic, B.; Kusic, Z. 2003: Early diagnosis of prostate cancer in finasteride treated BPH patients Anticancer Research 23(1b): 693-696
Valsecchi, R.; Leghissa, P.; Riva, M. 2004: Female androgenetic alopecia treated by finasteride: a case forward Acta Dermato-Venereologica 84(6): 488-489
Dogra, P.N.; Biswas, N.R.; Ravi, A.K.; Mani, K.; Kumar, V. 2005: Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia Journal of the Indian Medical Association 103(2): 108
Silke, B.; Guy, S.; Humphreys, J.E. 1992: Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension Journal of Human Hypertension 6(3): 221-225
Toiber, F.; Murthy, V.S. 1991: Prescribing and usage patterns of two antihypertensive agents: a comparison of terazosin and enalapril Hospital Formulary 26(10): 811
Mago, R.; Thase, M.E.; Rovner, B.W. 2013: Antidepressant-induced excessive sweating: clinical features and treatment with terazosin Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 25(3): 186-192
Lopatkin, N.A.; Apolikhin, O.I.; Sivkov, A.V.; Oshchepkov, V.N.; Egorov, A.A. 2002: Results of monotherapy with terazosin (kornam) in chronic infectious prostatitis patients Urologiia 2002(5 Suppl): 37-52
Tarasov, N.I.; Izmaĭlov, R.I. 2009: Efficacy of combined treatment of large prostatic adenoma with doxasozine and finasteride Urologiia 5: 40-45
Lee, S.W.; Juhasz, M.; Mobasher, P.; Ekelem, C.; Mesinkovska, N.A. 2018: A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women Journal of Drugs in Dermatology: Jdd 17(4): 457-463